Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Vaccines
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| GlaxoSmithKline | 12215835 | - | 1 lot Lot 1 | - |
| Merck Sharp & Dohme (UK) Limited | 00233687 | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 4 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Feb 2025 – Jan 2028 | £1,156,858 initial term | 2 | GlaxoSmithKline Merck Sharp & Dohme (UK) Limited | active |
Weightings from the notice.
Government spending data: These suppliers have received £269,016,838 in 42 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, Scottish Government, NHS England, UKRI (2018-02-28 to 2025-12-09).
Published by the buyer on this notice. Details change and are not updated here.